The global Polynucleotides Injectable market is a dynamic and promising industry that has shown significant growth in recent years. According to Kings Research recent market study, the Polynucleotides Injectable market was valued at USD 148.9 million in 2022 and is expected to reach USD 441.8 million by 2030, exhibiting a robust CAGR of 16.81% over the forecast period of 2022-2030. This report...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Tiếng Việt